| View |
|
DRP-12741-01
|
Gefitinib
|
Benefit
|
250 mg
|
Film-Coated Tablet
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
01 February 2023
|
30 September 2027
|
| View |
|
BRP-100-03
|
Epoetin Alfa
|
Epoeden
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
31 January 2023
|
14 December 2026
|
| View |
|
DRP-1182-05
|
Cetirizine Dihydrochloride
|
Cetirivin
|
10 mg
|
Tablet
|
H1-Receptor Antagonist (Antihistamine)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
21 July 2023
|
16 December 2028
|
| View |
|
DRP-4070-14
|
Fenofibrate
|
None
|
200 mg
|
Capsule
|
-
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 January 2023
|
19 October 2027
|
| View |
|
DRP-4089-03
|
Ondansetron (as hydrochloride)
|
Nauvent
|
2 mg/mL (4 mg/2 mL)
|
Solution for Injection (IM/IV)
|
-
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
31 January 2023
|
08 November 2027
|
| View |
|
DRP-4613-04
|
Cefaclor (as monohydrate)
|
Zeflor
|
50 mg/mL
|
Granules for Suspension (Oral Drops)
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
31 January 2023
|
15 March 2025
|
| View |
|
DRP-4976-24
|
Cefuroxime (as sodium)
|
Terxime
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial
|
Scott-Edil Advance Research Laboratories & Education Limited
|
India
|
Renewal
|
15 December 2023
|
27 November 2028
|
| View |
|
DRP-6164-03
|
Cefpodoxime (as proxetil)
|
Cefporich
|
200 mg
|
Film-Coated Tablet
|
Antibacterial
|
Brawn Laboratories Limited
|
India
|
Renewal
|
23 June 2024
|
22 May 2030
|
| View |
|
DRP-8032-01
|
Clobetasol Propionate
|
Activesol
|
500 mcg/g (0.05% w/w)
|
Cream
|
-
|
Y.S.P. Industries (M) Sdn. Bhd
|
Malaysia
|
CLIDP Conversion
|
31 January 2023
|
05 April 2025
|
| View |
|
DRP-8751-01
|
Methylprednisolone (as Sodium Succinate)
|
Methyxale - 500
|
500 mg
|
Powder for Solution for Injection (IM/IV)
|
-
|
Swiss Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 January 2023
|
04 January 2028
|
| View |
|
DRP-9136-02
|
Paracetamol
|
Aljesik
|
150mg/mL (300mg/2mL)
|
Solution for Injection (I.M./I.V.)
|
-
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
31 January 2023
|
11 September 2025
|
| View |
|
DRP-10748-01
|
Atorvastatin (as calcium)
|
Mayor-40
|
40 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 January 2023
|
15 November 2026
|
| View |
|
DRP-12012-02
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Telvost
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 January 2023
|
30 May 2027
|
| View |
|
DRP-12077-01
|
Cefuroxime (as Sodium)
|
Infekor
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
-
|
Swiss Parenterals Ltd
|
India
|
CLIDP Conversion
|
31 January 2023
|
08 June 2027
|
| View |
|
DRP-12184-01
|
Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate
|
Reflucon
|
500mg /213mg/325mg per 10mL
|
Oral Suspension
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 January 2023
|
27 June 2027
|
| View |
|
DRP-12494-01
|
Clonidine Hydrochloride
|
Cataclon 150
|
150 mcg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
31 January 2023
|
19 August 2027
|
| View |
|
DRP-12506-01
|
Ondansetron (as Hydrochloride)
|
Setronad
|
2mg/mL (8mg/4mL) (4mg/2mL)
|
Solution for Injection
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
31 January 2023
|
22 August 2027
|
| View |
|
DRP-12622-03
|
Montelukast (as sodium)+ Levocetirizine Hydrochloride
|
Lymont
|
10mg/5mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 January 2023
|
29 June 2027
|
| View |
|
DRP-12791-01
|
Amlodipine (as Besilate) + Hydrochlorothiazide
|
Kodipin HCTZ
|
10 mg/12.5 mg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
31 January 2023
|
28 October 2027
|
| View |
|
DRP-12808-01
|
Amlodipine (as Besilate) + Hydrochlorothiazide
|
Kodipin HCTZ
|
5 mg/12.5 mg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
31 January 2023
|
08 October 2027
|